Showing results (131-140 of 188) with videos related to

Sort By:
Pageof 19
Pharmacology, Biochemistry, and Behavior|October 17, 2013
Sexual side effects of serotonergic antidepressants: mediated by inhibition of serotonin on central dopamine release?Elisabeth Y Bijlsma, Johnny S W Chan, Berend Olivier, et al.
Scientific Reports|December 1, 2018
Glutamatergic and dopaminergic modulation of cortico-striatal circuits probed by dynamic calcium imaging of networks reconstructed in microfluidic chipsBenjamin Lassus, Jérémie Naudé, Philippe Faure, et al.
European Journal of Pharmacology|December 11, 2017
Distinctive binding properties of the negative allosteric modulator, [<sup>3</sup>H]SB269,652, at recombinant dopamine D<sub>3</sub> receptorsIrene Fasciani, Ilaria Pietrantoni, Mario Rossi, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 24, 2004
S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: I. Cellular, electrophysiological, and neurochemical profile in comparison with ropiniroleMark J Millan, Didier Cussac, Alain Gobert, et al.
European Journal of Pharmacology|February 23, 2010
Inhibitory and facilitory actions of isocyanine derivatives at human and rat organic cation transporters 1, 2 and 3: a comparison to human alpha 1- and alpha 2-adrenoceptor subtypesAnne Amphoux, Mark J Millan, Alex Cordi, et al.
Molecular Pharmacology|December 18, 2007
Inverse agonist and neutral antagonist actions of antidepressants at recombinant and native 5-hydroxytryptamine2C receptors: differential modulation of cell surface expression and signal transductionBenjamin Chanrion, Clotilde Mannoury la Cour, Sophie Gavarini, et al.
Biological Psychiatry|February 13, 2021
TAAR1-Dependent and -Independent Actions of Tyramine in Interaction With Glutamate Underlie Central Effects of Monoamine Oxidase InhibitionIoannis Mantas, Theodosia Vallianatou, Yunting Yang, et al.
International Journal of Molecular Sciences|August 27, 2021
Trace Amine-Associated Receptor 1 Contributes to Diverse Functional Actions of O-Phenyl-Iodotyramine in Mice but Not to the Effects of Monoamine-Based AntidepressantsIoannis Mantas, Mark J Millan, Benjamin Di Cara, et al.
Psychopharmacology|August 12, 2011
Lifelong CRF overproduction is associated with altered gene expression and sensitivity of discrete GABA(A) and mGlu receptor subtypesChristiaan H Vinkers, Hendrikus Hendriksen, Ruud van Oorschot, et al.
Neuropharmacology|June 12, 2020
Dual-acting agents for improving cognition and real-world function in Alzheimer's disease: Focus on 5-HT6 and D3 receptors as hubsMark J Millan, Anne Dekeyne, Alain Gobert, et al.
Pageof 19